News from the FDA/CDC
News from the FDA/CDC
CDC chief lays out attack plan for COVID variants
Public health leaders are ramping up genome sequencing of the SARS-CoV-2 virus and ensuring that sampling is geographically representative.
News from the FDA/CDC
CDC panel: No COVID-19 vaccine safety surprises
FDA/CDC
Anaphylaxis cases after COVID-19 vaccine rising but still rare: CDC
News from the FDA/CDC
Moderna’s COVID-19 vaccine deemed ‘highly effective,’ but further studies needed
The primary safety endpoint was to characterize the safety of the vaccine following one or two doses.
News from the FDA/CDC
Child abuse visits to EDs declined in 2020, but not admissions
Proportion of visits related to child abuse and neglect that resulted in hospitalizations increased from 2019 to 2020.
News from the FDA/CDC
Vaccine rollout on track, expect 300 million doses through March: Feds
Operation Warp Speed officials expect to have 300 million doses of COVID-19 vaccines to distribute across the U.S. by March 31.
FDA/CDC
CDC panel delves into priorities for COVID vaccine distribution
News from the FDA/CDC
50.6 million tobacco users are not a homogeneous group
Traditional cigarettes are the still the most popular choice, but young adults prefer the electronic variety.
FDA/CDC
FDA authorizes baricitinib combo for COVID-19
FDA/CDC
FDA approves first at-home COVID-19 test kit
The Lucira COVID-19 All-In-One Test-Kit is a single-use test that has a nasal swab to collect samples for people ages 14 and older.
FDA/CDC
Nearly 10% of hospitalized patients with COVID-19 later readmitted